Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.280
-0.040 (-3.03%)
Aug 15, 2025, 10:16 AM - Market open
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $5.40 million as of August 15, 2025. Its market cap has increased by 53.69% in one year.
Market Cap
5.40M
Enterprise Value
5.02M
1-Year Change
53.69%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $5.40M, a decrease of -86.88%. That is a compound annual growth rate of -43.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 5.57M | 41.93% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 598.48B |
| Johnson & Johnson | 419.56B |
| AbbVie | 358.43B |
| UnitedHealth Group | 245.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.98B |